Mycobacterium tuberculosis shikimate kinase inhibitors: Design and simulation studies of the catalytic turnover

被引：0
|
作者：
机构：
[1] Blanco, Beatriz
[2] Prado, Verónica
[3] Lence, Emilio
[4] Otero, José M.
[5] Garcia-Doval, Carmela
[6] Van Raaij, Mark J.
[7] Llamas-Saiz, Antonio L.
[8] Lamb, Heather
[9] Hawkins, Alastair R.
[10] González-Bello, Concepción
来源：
González-Bello, C. (concepcion.gonzalez.bello@usc.es) | 1600年 / American Chemical Society卷 / 135期
关键词：
77;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] The conserved Lysine69 residue plays a catalytic role in Mycobacterium tuberculosis shikimate dehydrogenase
    Rodrigues V.
    Breda A.
    Santos D.
    Basso L.
    BMC Research Notes, 2 (1)
  • [32] Thymidine (monophosphate) analogues as Mycobacterium tuberculosis thymidylate kinase inhibitors
    Van Rompaey, P
    Veerle, V
    Pochet, S
    Munier-Lehmann, H
    Froeyen, M
    Herdewijn, P
    Van Calenbergh, S
    CHEMISTRY OF NUCLEIC ACID COMPONENTS, 2002, 5 : 393 - 395
  • [33] A new family of inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase
    Gasse, C.
    Huteau, V.
    Douguet, D.
    Munier-Lehmann, H.
    Pochet, S.
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2007, 26 (8-9): : 1057 - 1061
  • [34] Design, synthesis and target validation studies of aminothiazoles (ATs) as potent inhibitors of Mycobacterium tuberculosis
    Zuniga, Edison S.
    Kesicki, Edward A.
    Odingo, Joshua
    Howell, Heather
    Parish, Tanya
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [35] Crystal structure of shikimate kinase from Mycobacterium tuberculosis reveals the dynamic role of the LID domain in catalysis
    Gu, YJ
    Reshetnikova, L
    Li, Y
    Wu, Y
    Yan, HG
    Singh, S
    Ji, XH
    JOURNAL OF MOLECULAR BIOLOGY, 2002, 319 (03) : 779 - 789
  • [36] A multifaceted approach to identify non-specific enzyme inhibition: Application to Mycobacterium tuberculosis shikimate kinase
    Alturki, Mansour S.
    Fuanta, Ngolui Rene
    Jarrard, Madison A.
    Hobrath, Judith V.
    Goodwin, Douglas C.
    Rants'o, Thankhoe A.
    Calderon, Angela I.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (04) : 802 - 808
  • [37] DESIGN AND SYNTHESIS OF NOVEL MYCOBACTERIUM TUBERCULOSIS DHFR INHIBITORS
    Lele, Arundhati C.
    Khambete, Mihir P.
    Raju, Archana
    Ray, Muktikanta
    Rajan, M. G. R.
    Degani, Mariam S.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2016, 7 (06):
  • [38] Design and in vitro evaluation of five inhibitors of Mycobacterium tuberculosis
    Bartzatt, Ronald
    Cirillo, Suat L. G.
    Cirillo, Jeffrey D.
    LETTERS IN DRUG DESIGN & DISCOVERY, 2007, 4 (02) : 137 - 143
  • [39] Inhibition of Shikimate Kinase and Type II Dehydroquinase for Antibiotic Discovery: Structure-Based Design and Simulation Studies
    Gonzalez-Bello, Concepcion
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (09) : 960 - 977
  • [40] Synthesis, molecular docking, and biological evaluation of novel 1,2,4-triazole-isatin derivatives as potential Mycobacterium tuberculosis shikimate kinase inhibitors
    Dadlani, Vedika G.
    Chhabhaiya, Heta
    Somani, Rakesh R.
    Tripathi, Pushpendra K.
    CHEMICAL BIOLOGY & DRUG DESIGN, 2022, 100 (02) : 230 - 244
12345